2023 Was a tough yr with the biopharma business, with various companies downsizing and restructuring their workforces to stay afloat. You can find indications of Restoration, as mergers and acquisitions picked up over the pharmaceutical and everyday living sciences industry within the latter A part of 2023 and have continued https://sites.google.com/view/bio-sites/blog